The viral vector and plasmid DNA manufacturing market offers growth opportunities in gene therapies, contract manufacturing, and emerging markets like Asia-Pacific. Key trends include rising demand ...

Viral vectors are vital for the cell and gene therapy industry. However, long production timelines, combined with quality and consistency issues, mean that growing demand is outstripping supply. The ...

Gene therapies can correct diseases at their genetic core, but their success hinges on viral vector manufacturing. As gene therapy technology becomes more advanced, producing viral vectors becomes ...

PHILADELPHIA--(BUSINESS WIRE)--VintaBio, a biotech manufacturing technology company specializing in high-yield, high-purity viral vector production for reliable gene therapy access, will present ...

A mathematical model could help reduce the experimental effort needed to develop production processes for gene therapies. The digital twin, developed by a team at University College London (UCL) in ...

The AAV vector manufacturing market is mainly fueled by the expanding landscape of gene therapy research and development, as AAV vectors are extensively utilized for therapeutic gene delivery because ...

Efficient viral vector production is essential for the cost-effective manufacture of cell and gene therapies. Many of the current production workflows are reliant on basal media in batch-mode, which ...

(MENAFN- EIN Presswire) EINPresswire/ -- The viral vector manufacturing market is dominated by a mix of global biopharmaceutical manufacturing companies and specialized gene therapy technology ...

Advances company’s ambition to provide fully integrated and comprehensive solution for viral vector manufacturing Mirus Bio’s leading GMP transfection reagents complement company’s upstream ...

CDMO ProBio, the biologics subsidiary of GenScript, expanded its plasmid DNA and viral vector production capacity with the opening of new manufacturing facility in Hopewell, New Jersey. The site, ...